Back to results list
Show full item record
Please use this identifier to cite or link to this item:
|Title:||S100A4 is critical for a mouse model of allergic asthma by impacting mast cell activation||Authors:||Wu, T
|Issue Date:||Jul-2021||Source:||Frontiers in immunology, July 2021, v. 12, 692733||Abstract:||Background: The calcium-binding protein S100A4 demonstrates important regulatory roles in many biological processes including tumorigenesis and inflammatory disorders such as allergy. However, the specific mechanism of the contribution of S100A4 to allergic diseases awaits further clarification.
Objective: To address the effect of S100A4 on the regulation of mast cell activation and its impact on allergy.
Methods: Bone marrow-derived cultured mast cells (BMMCs) were derived from wild-type (WT) or S100A4-/- mice for in vitro investigation. WT and S100A4-/- mice were induced to develop a passive cutaneous anaphylaxis (PCA) model, a passive systemic anaphylaxis (PSA) model, and an ovalbumin (OVA)-mediated mouse asthma model.
Results: Following OVA/alum-based sensitization and provocation, S100A4-/- mice demonstrated overall suppressed levels of serum anti-OVA IgE and IgG antibodies and proinflammatory cytokines in serum, bronchoalveolar lavage fluid (BALF), and lung exudates. S100A4-/- mice exhibited less severe asthma signs which included inflammatory cell infiltration in the lung tissue and BALF, and suppressed mast cell recruitment in the lungs. Reduced levels of antigen reencounter-induced splenocyte proliferation in vitro were recorded in splenocytes from OVA-sensitized and challenged mice that lacked S100A4-/-. Furthermore, deficiency in the S100A4 gene could dampen mast cell activation both in vitro and in vivo, evidenced by reduced β-hexosaminidase release and compromised PCA and PSA reaction. We also provided evidence supporting the expression of S100A4 by mast cells.
Conclusion: S100A4 is required for mast cell functional activation, and S100A4 may participate in the regulation of allergic responses at least partly through regulating the activation of mast cells.
|Publisher:||Frontiers Research Foundation||Journal:||Frontiers in immunology||EISSN:||1664-3224||DOI:||10.3389/fimmu.2021.692733||Rights:||© 2021 Wu, Ma, Jin, He, Chen, Zhang, Yuan, Yang, Zhong, Zhou, Xiang and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
The following publication Wu T, Ma L, Jin X, He J, Chen K,Zhang D, Yuan R, Yang J, Zhong Q,Zhou H, Xiang Z and Fang Y (2021)S100A4 Is Critical for a MouseModel of Allergic Asthma byImpacting Mast Cell Activation.Front. Immunol. 12:692733 is available at https://doi.org/10.3389/fimmu.2021.692733
|Appears in Collections:||Journal/Magazine Article|
Show full item record
Citations as of May 15, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.